CL King Downgrades SurModics (SRDX) to Neutral
SRDX Hot Sheet
Rating Summary:2 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 12 | New: 36
CL King downgrades SurModics (Nasdaq: SRDX) from Accumulate to Neutral.
SurModics, Inc. engages in the development, manufacture, and sale of surface modification and drug delivery technologies to the healthcare industry.
SurModics, Inc. engages in the development, manufacture, and sale of surface modification and drug delivery technologies to the healthcare industry.
You May Also Be Interested In
- UPDATE: UBS Downgrades Wisconsin Energy (WEC) to Neutral; Taking Some Off The Table
- Barclays Reiterates Cautious Stance on hhgregg (HGG); Lowering PT & Estimates
- Barclays Still Sees Pandora (P) Struggling to Profitability; Maintains 'Underweight'
Create E-mail Alert Related Categories
DowngradesRelated Entities
CL KingSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
